This content was written and submitted by the supplier. It has only been modified to comply with this publication’s space and style.
VWR, a leading, global, independent provider of laboratory products, services and solutions, announced today that it has acquired Therapak Corporation and Therapak Pharma Services Limited, suppliers of pre-packaged convenience kits and procedure packs for the clinical trial, pharmaceutical, diagnostic and clinical laboratory industries. This acquisition will strengthen VWR's product and service offering and provide its customers with valuable additional solutions capabilities to achieve its goals.
"We are pleased to be part of VWR's extensive supply chain for products and services," said Todd Gates, President of Therapak. "We look forward to accelerating our development and reach with a trusted, global organization like VWR."
"As a previous supplier to VWR, Therapak has proved to be a leader of procedure and kit assembly, making them a great asset to our organization," said Mark McLoughlin, SVP and President, Americas Lab and
Distribution Services of VWR. "We have a similar approach to supporting our customers by understanding customer requirements, then identifying solutions that leverage our knowledge, experience, resources and
technology."
Established in 1999, Therapak has two locations in the United States and one in the United Kingdom totaling 240,000 square feet. Therapak's services include standard and custom component and kit outsourcing,
moderate to complex assembly, process control and serial labeling, packaging of courier, medical, diagnostic and pharmaceutical products in a variety of temperature sensitive materials and more.
Financial details of this acquisition remain confidential.
